Pharmaceutical compositions

Details for Australian Patent Application No. 2005224030 (hide)

Owner Novartis AG

Inventors Schneeberger, Ricardo; Wirth, Wolfgang; Baumberger, Anton; Muhrer, Gerhard

Agent Davies Collison Cave

Pub. Number AU-B-2005224030

PCT Pub. Number WO2005/089718

Priority 0424727.6 09.11.04 GB; 0406515.7 23.03.04 GB

Filing date 22 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 25 September 2008

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089718 Priority application(s): WO2005/089718

25 September 2008 Application Accepted

  Published as AU-B-2005224030

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224031-Shelf stable product with living microorganisms

2005224028-Y4 selective receptor agonists for therapeutic interventions